Second CT laser mammography system sold in Italy

7 February 2005

FORT LAUDERDALE, Fla, USA. Imaging Diagnostic Systems, Inc. (BULLETIN BOARD: IMDS) announced today that it has shipped and sold a second CTLM(R) system to its distributor Biomedical International SNC for installation at the Biomedical Mammography Center, Alba Adriatica, Teramo, Italy.

"We recently began marketing the CTLM system and these new sales demonstrate that the revolutionary laser optical breast imaging technology is gaining acceptance in Italy as a beneficial diagnostic tool," stated G. Luciano Perazzi, President of Biomedical International.

Tim Hansen, Imaging Diagnostic Systems CEO, stated, "This is the fourth operating CTLM system in Italy and the second sale in the country. We will soon have operating CTLM systems in the university setting, general hospitals and now a mammography center. Wherever women receive conventional x-ray mammography exams, the CTLM may serve a useful adjunctive service."

The CTLM(R) system is the first patented breast imaging system that utilizes state-of-the-art laser technology and patented algorithms to create 3-D cross-sectional images of the breast. It is a non-invasive, painless examination that does not expose the patient to radiation or require breast compression. Imaging Diagnostic Systems has received CE Marking, CMDCAS (Canada), Canadian License, China SFDA approval, UL listing, ISO 9001:2000- 13488 certification and FDA export certification for its CT Laser Breast Imaging system. The Company is seeking PreMarket Approval (PMA) from the Food and Drug Administration (FDA) for its CTLM(R) system to be used as an adjunct to mammography.

Please visit Imaging Diagnostic Systems' website at: http://www.imds.com/ for additional information.

Source: Imaging Diagnostic Systems, Inc.

CONTACT: Investor Relations, Rick Lutz, +1-404-261-1196, or
lcgroup@mindspring.com, for Imaging Diagnostic Systems, Inc.